Imago Biosciences, Inc., A Subsidiary Of Merck & Co., Inc., (rahway, New Jersey Usa)

This study tested an experimental pill called bomedemstat in 20 adults with polycythemia vera, a rare blood cancer that causes too many red blood cells. The goal was to see if the drug could safely lower red blood cell levels without needing frequent blood removal (phlebotomy). P…

This study tested an experimental pill called Bomedemstat in 73 adults with essential thrombocythemia, a rare blood condition causing too many platelets. Participants had already tried at least one standard treatment without success. The main goals were to check safety and see if…

This study looked at the long-term safety and effectiveness of the drug bomedemstat in 81 people with myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Participants had already taken bomedemstat in earlier studies and continued treatment to see how well it contr…